According to a recent LinkedIn post from Resilience Care, the company was represented by Dr. Daniel Fallscheer in a panel discussion at the French Embassy in Berlin ahead of the DMEA – Connecting Digital Health conference. The event, organized by Business France, reportedly focused on the patient journey in France and Germany and featured stakeholders from policy, care, research, and innovation.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The post indicates that the panel explored both challenges and opportunities in aligning healthcare systems across borders. It also emphasizes the role of telemonitoring and patient-reported outcomes in enhancing continuity, visibility, and personalization of care pathways.
For investors, this participation suggests that Resilience Care is positioning itself within key European digital health conversations, particularly around cross-border care coordination. Engagement at a high-profile policy and industry forum could support the company’s visibility with potential partners, payers, and regulators, which may be relevant for future market access and collaboration opportunities.
While the post does not reference specific products, revenue impacts, or new commercial agreements, it signals strategic alignment with emerging trends in data-driven and remote patient management. Such positioning may help Resilience Care benefit from long-term shifts toward telemonitoring, outcome-based care models, and cross-country interoperability in European healthcare markets.